National Brain Tumor Society Impact Report
December 31, 2025
News & Publications
In The News
ROI NJ with John Harrington – Atlantic Health treats first patient in Northeast for brain tumor with new cellular immunotherapy
December 22, 2025
TapInto with Rob Seman – Atlantic Health treats first patient in Northeast for glioblastoma with new cellular immunotherapy in Phase 2 clinical trial
December 22, 2025
Biotech 2050 with Jay Valencia – Jay Hartenbach, President & COO, Diakonos Oncology on Reprograming Cancer Immunity Breakthrough
December 10, 2025
Clinical Trials Arena with Annabel Kartal Allen – Addressing the glioblastoma treatment gap
December 3, 2025
Press Releases
Diakonos Oncology to Present Corporate Overview and Participate in Panel at 2026 Biotech Showcase
December 15, 2025
Diakonos Oncology Awarded Multi-Million-Dollar Research Grant by the Cancer Prevention and Research Institute of Texas to Advance DOC1021 in Refractory Melanoma
December 10, 2025
Diakonos Oncology Presents Promising Preliminary Data from Phase 1 Study of DOC1021 Cell-Based Immunotherapy in Pancreatic Cancer at Society for Immunotherapy of Cancer 40th Annual Meeting
November 7, 2025
Pancreatic Cancer Clinical Trial Data for Diakonos Oncology’s DOC1021 Cell-Based Immunotherapy to be Presented at the Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting
October 27, 2025
Donna Rill New Hire
August 12, 2025
Company Presentations
Diakonos Oncology to Present Corporate Overview and Participate in Panel at 2026 Biotech Showcase
December 15, 2025
Medical Digest SITC Interview – Phase I Trial of DOC1021 Cell-Based Immunotherapy for Resectable or Borderline Resectable Ductal Adenocarcinoma
November 27, 2025
Diakonos Oncology Presents Promising Phase I Results of Dubodencel (DOC1021) at the ASCO 2025 Annual Meeting
June 2, 2025
Diakonos Oncology Presents Phase I Analysis of DOC1021 at the 2025 American Academy of Neurology Annual Meeting
April 9, 2025
2025 Spring Symposium hosted by the William T. Shearer Center for Human Immunobiology
March 7, 2025
Publications
Science Translational Medicine: A Unique Subset of Cytotoxic Effector Memory T-cells Enhances CAR T-cell Function against Pancreatic Ductal Adenocarcinoma. Konduri V, Joseph S, Byrd TT, et al.
May 5, 2022
FASEB Journal: MHC class I and II peptide homology regulates the cellular immune response. FASEB. Halpert MM, Konduri V, Liang D, et al.
April 16, 2020
Cancer Gene Therapy: Dendritic cell vaccination plus low-dose Doxorubicin for the treatment of spontaneous canine hemangiosarcoma. Konduri V*, Halpert MM*, et al. Cancer Gene Therapy.
January 23, 2019
Frontiers in Immunology: AIMp1 Potentiates TH1 polarization and is critical for effective antitumor and antiviral immunity. Liang D, Tian L, You R, et al.
January 15, 2018
OncoImmunology: Chemo-immunotherapy mediates durable cure of orthotopic KrasG12D/p53-/- pancreatic ductal adenocarcinoma. Oncoimmunology. Konduri V, Li D, Halpert MM, et al.
July 22, 2016
Connect with us on social
